MediWound Ltd. (MDWD): Stock Price

The asset value of MediWound Ltd. (MDWD) reflected in this chart stands at 12.95. MediWound Ltd. (MDWD) is developing an innovative scalpel-free burn wound cleansing method, granting the company complete pricing power. Its position is strengthening due to the success of NexoBrid and exclusive agreements with Western military agencies, although the business faces challenges regarding the scaling of enzyme production and strict regulatory oversight.

MediWound Ltd. - MDWD Stock Quotes (period 07/04/2022 - 11/14/2026)

Comprehensive metric breakdowns and analytics for MediWound, Ltd. (MDWD)

- stock value and consensus price forecast:

Price Chart MediWound Ltd.|MDWD - Consensus Target

- stock exchange capitalization data:

Market Capitalization MediWound Ltd|MDWD - Business Value

- book capitalization information:

Accounting Value per Share MediWound Ltd.|MDWD - Company Net Assets|Market Capitalization to Book Value Ratio mediwound.com|MDWD - Total Business Assets

- business debt structure and liquidity details:

- financial results and valuation multiples details:

MDWD - Profit After Payment of Taxes|Expected Profit MediWound Ltd.|MDWD - Price to Earnings Ratio|Forward P/E Multiple MediWound Ltd.|MDWD - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MediWound Ltd|MDWD - Operating profit before amortization|Net earnings per share for the last 12 months MediWound Ltd.|MDWD - Earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months mediwound.com|MDWD - Net earnings per share growth this year|Earnings growth forecast for next year MediWound Ltd.

- total revenue and sales volume data:

MDWD - Company Total Revenue|Projected Sales Volume MediWound Ltd.|MDWD - Market Cap to Revenue Ratio|Forward P/S Multiple MediWound Ltd

Fundamental valuation:MediWound

The development of partnerships between MediWound Ltd. (MDWD) and burn centers and military structures directly impacts the market perception of their drug distribution prospects. Analyzing the asset value retrospectively, an investor sees not a static business, but a dynamic capital valuation where any price anomalies serve as a leading indicator of hidden threats or insider sentiment even before the publication of official financial reports.

Competitors of MediWound Ltd. (MDWD)